Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Balance Sheets (Unaudited)

v3.10.0.1
Condensed Consolidated Balance Sheets (Unaudited) - USD ($)
Sep. 30, 2018
Mar. 31, 2018
Current assets    
Cash $ 5,078,605 $ 6,974,070
Accounts receivable 0 74,813
Prepaid expenses and other current assets 89,343 181,367
Total current assets 5,167,948 7,230,250
Property and equipment, net 16,094 27,552
Patents, net 71,250 75,832
Deposits 17,131 18,270
Total assets 5,272,423 7,351,904
Current liabilties    
Accounts payable 91,879 124,450
Due to related parties 98,866 90,366
Convertible notes payable, net 901,727 0
Other current liabilities 168,356 263,141
Total current liabilities 1,260,828 477,957
Convertible notes payable, net 0 841,153
Total liabilities 1,260,828 1,319,110
Stockholders' Equity    
Common stock, par value $0.001 per share; 30,000,000 shares authorized as of September 30, 2018 and March 31, 2018; 17,834,560 and 17,739,511 shares issued and outstanding as of September 30, 2018 and March 31, 2018, respectively 17,835 17,740
Additional paid-in capital 106,107,157 105,574,014
Accumulated deficit (101,997,287) (99,457,714)
Total Aethlon Medical, Inc. stockholders' equity before noncontrolling interests 4,127,705 6,134,040
Noncontrolling interests (116,110) (101,246)
Total stockholders' equity 4,011,595 6,032,794
Total liabilities and stockholders' equity $ 5,272,423 $ 7,351,904